ライフサイエンスコーパス: outlook

1 discuss current challenges, and present our outlook.

2 directions and hence create an instrumental outlook.

3 catalyzed by ArMs and a concluding critical outlook.

4 1alpha-positive tumors has a better clinical outlook.

5 xcluded from participation because of a poor outlook.

6 provements in domains of insomnia, pain, and outlook.

7 he current status of oncology and its future outlook.

8 reported; IBC patients have a poor long-term outlook.

9 , and patients with this disease have a poor outlook.

10 making, decision regret, and cancer-related outlook.

11 yloidosis that affects the heart have a poor outlook.

12 sely with its incidence, indicating a dismal outlook.

13 L who otherwise would have an extremely poor outlook.

14 rt may be influenced by pain and psychologic outlook.

15 profound changes in therapeutic options and outlook.

16 e been largely responsible for this improved outlook.

17 olerant to hydroxycarbamide (HC) have a poor outlook.

18 cancer is important in forecasting clinical outlook.

19 ctivity, activity, efficiency, and synthetic outlook.

20 ive of this original study as well as future outlook.

21 The review is complemented with a short outlook.

22 Finally, we ended with an outlook.

23 ing the bromodomains of KATs, and present an outlook.

24 ghlighting current directions and the future outlook.

25 and communicate uncertainty in future energy outlooks.

26 Conclusion and outlook 59 Acknowledgements 60 References 60 To meet the

27 Outlook 66 Acknowledgements 66 References 66 Plasmodesma

28 The power consumption of the cloud based Outlook (8%) and Excel (17%) was lower than their tradit

29 been either too regional or global in their outlook [8-11].

30 Conclusions and outlook 911 Acknowledgements 912 References 912 Subtilas

31 However, the group with a positive outlook about the future of radioimmunotherapy predicted

32 rmation Administration (EIA)'s Annual Energy Outlook (AEO), for investment and policy decisions.

33 The quantitative outlook also brings up the issue of precision, and the u

34 of the 1930s left a lasting impression on my outlook and career aspirations.

35 Furthermore, outlook and future directions of modelling and simulatio

36 ls infected with HIV-1 could indicate a poor outlook and should therefore prompt concern at any stage

37 Lastly, outlook and the future development of biosensors for the

38 ific research and discuss possible problems, outlooks and future needs in the use of optical rulers f

39 Bold outlooks and new methods for data analysis and presentat

40 ution of lifestyle measures with a long-term outlook, and an avoidance of heavily marketed fads.

41 is important in life, maintaining a positive outlook, and embracing a philosophy that stresses work/l

42 n the community's motivations, philosophical outlook, and methods.

43 n-symptom association such as patients' sex, outlook, and response to treatment.

44 Finally, a summary and outlook are offered.

45 Finally, conclusions and future outlook are presented and discussed.

46 To close, a conclusion and outlook are provided, pointing out future designs and de

47 discussed, and corresponding strategies and outlooks are suggested.

48 s who participated in the meeting provide an outlook at some of those key issues and concepts.

49 articipated at the meeting provide a concise outlook at the most pressing unmet research and clinical

50 Presented herein is a unique personal outlook conceptualizing the powerful proximity-enhanced

51 compliance and to an individual's strategic outlook during the exchange.

52 The future outlook encompasses rational and sustainable use of effe

53 vailable preclinical and clinical tools, the outlook for academic-community-industry partnerships in

54 sources, and a more systematic translational outlook for accumulation of evidence may augment the pub

55 t that overexpression of TLX1 confers a good outlook for adults with T-cell acute lymphoblastic leuka

56 We describe the outlook for an integration between Kurzban et al.'s prof

57 ined and information gained, and discuss the outlook for biochemical approaches to study NHEJ.

58 ward pluripotency has completely altered the outlook for biomedical research.

59 to the brain could dramatically improve the outlook for cancer survivors and enable more effective u

60 We also discuss the outlook for CAR T-cell therapies, including managing tox

61 new therapeutic strategies suggest that the outlook for CG as a poorly understood and therapeuticall

62 The outlook for children with cancer has improved substantia

63 f special importance given the current bleak outlook for chronic progressive fibrotic diseases, such

64 Scenario analyses explore the outlook for CO2, which under best-case conditions could

65 rticle reviews the current status and future outlook for colorectal cancer screening, including a dis

66 vantages and shortcomings, commenting on the outlook for development of novel voltage imaging methods

67 The challenges and outlook for drugging the PI3 kinome are discussed in the

68 climate may thus interact to give a positive outlook for exploited high-latitude marine resources.

69 n hybrid solar cells, and finally provide an outlook for future directions of this extraordinarily ri

70 ugh this line of research offers an exciting outlook for future epigenetic research in PTSD, importan

71 tive trials should be pursued to improve the outlook for future interventional trials in sepsis.

72 ighlight seminal experiments, and present an outlook for future progress.

73 A detailed outlook for future research on MXenes is also presented.

74 iviral functions, current limitations and an outlook for future research.

75 ve of our analysis was to quantify the water outlook for future shale oil development using the Eagle

76 ir current use and future directions, and an outlook for future technological development.

77 cuses on the legacy of these studies and the outlook for future treatment of cardiac diseases with st

78 iber into adenovirus vectors may improve the outlook for gene delivery to human airway epithelia.

79 enib as palliative therapy have improved the outlook for HCC patients.

80 st year has continued the initial optimistic outlook for human papillomavirus vaccination and it is l

81 ppresses HIV-1 replication, transforming the outlook for infected patients.

82 of top-down mass spectrometry as well as an outlook for its future.

83 nd the pharmaceutical industry can this grim outlook for liver disease worldwide be reversed.

84 The outlook for myeloma patients has greatly improved over t

85 considered a uniformly fatal condition, the outlook for newborns with HLHS has been altered dramatic

86 Finally, we discuss the outlook for novel technologies that are changing the sta

87 one-marrow transplantation have improved the outlook for patients with acute leukaemia.

88 The outlook for patients with acute promyelocytic leukaemia

89 d of the 20th century to provide an improved outlook for patients with autoimmune neutropenia.

90 ogenous insulin has dramatically changed the outlook for patients with diabetes.

91 Purpose The general outlook for patients with diffuse large B-cell lymphoma

92 significantly improved the intermediate-term outlook for patients with HLHS.

93 s with effective therapies should change the outlook for patients with lysosomal disorders with neuro

94 and bortezomib has dramatically improved the outlook for patients with MM, but their relative benefit

95 The outlook for patients with neurogenic bladder has been tr

96 The outlook for patients with refractory and relapsed acute

97 The outlook for patients with the disease has improved stead

98 The outlook for patients with thin invasive melanoma is posi

99 iminished the stigma and greatly altered the outlook for patients.

100 ted with existing biosensors, and provide an outlook for PC-based biosensors and their promise at the

101 lications have resulted in a more optimistic outlook for people with diabetes.

102 culations about potential mechanisms and the outlook for potential therapeutic interventions.

103 ditions on the mountain, and signify a bleak outlook for silverswords if these trends continue.

104 tive prices and consumer acceptance, and the outlook for single-cell organisms to replace fish oil is

105 ic intra-arterial radiation, may improve the outlook for some patients with resectable cancer.

106 with AMA have very early PBC, to assess the outlook for such patients, and to follow the progression

107 rom complications and a significantly better outlook for survival can be assured to patients with acu

108 We conclude the review with an outlook for the clinical use of this highly promising, b

109 s from local to global scales, improving the outlook for the environment and people into the future.

110 America suggest a mixed (positive/negative) outlook for the environmental mercury problem.

111 The study indicates a promising new outlook for the examination of prostanoid receptor-G-pro

112 ion, we consider the medium- and longer-term outlook for the field.

113 obal biogeochemical processes, along with an outlook for the future challenges in the field.

114 ials currently on the market and provides an outlook for the future developments needed to improve re

115 cannot be studied with this technique and an outlook for the future is provided.

116 hen performing VR experiments and provide an outlook for the future of this exciting experimental too

117 revent further coral decline and improve the outlook for the Great Barrier Reef.

118 ds, setting it in context and discussing the outlook for the next few years.

119 effects are best measured, and the long-term outlook for the poisoned child.

120 This provides a positive outlook for the potential of gene therapy to cure adult

121 ore than satisfactory suggesting interesting outlook for the proposed device.

122 We also provide an outlook for the sector, highlighting key technical chall

123 d improve both the ethical and the technical outlook for the use of human fetal tissue in clinical tr

124 Our findings paint a positive demographic outlook for these indigenous populations, though long-te

125 ricular lesions has drastically improved the outlook for these patients.

126 a perspective into the future challenges and outlook for this burgeoning field.

127 ic option for CIN2/3, changing the treatment outlook for this common disease.

128 ation have improved in recent times, and the outlook for this patient group is no longer hopeless.

129 d appropriate treatment, since the long-term outlook for untreated patients with dominant soft tissue

130 Finally, a concise outlook for utilizing POPs for carbon capture is discuss

131 Although the survival outlook for WT patients has improved greatly over time,

132 The presented water outlooks for HF and FP water volumes can be used to asse

133 lp explain the discrepancy between promising outlooks for many NP formulations in preclinical studies

134 sful in solving engineering tasks ranging in outlook from the molecular to the astronomical.

135 patients with GBM is under 10 months and the outlook has hardly improved over the past 20 years.

136 The outlook has improved dramatically in recent years with t

137 ix multi-item scales: Current Health, Health Outlook, Health Distress, Fleming Self-Esteem, Bergner P

138 (1) outlook in PD is heterogeneous, with most dying or devel

139 ncer patients who have a significantly worse outlook in prognosis and a potential differential respon

140 Their future outlook in regenerative medicine including the current c

141 The outlook in Takayasu arteritis has improved over the last

142 tion, which provides a potentially rewarding outlook in that centrosome declustering agents hold prom

143 The outlook in the adjuvant setting is much brighter with th

144 le deposits has significantly changed energy outlooks in both the US and world.

145 Future outlooks in this area are also discussed.

146 The future outlook includes developing conjugated patterned hydroge

147 aspects of BTK inhibitors, and we provide an outlook into clinical development and open questions reg

148 s clinically relevant aspects and provide an outlook into future biologically oriented therapeutic st

149 I conclude with a short outlook into how combined biophysical and cell biologica

150 Our results open outlooks into potentially undiscovered Haemosporidian di

151 A detailed outlook is finally given regarding important future appl

152 An outlook is given on how especially comparative oncology

153 Finally, in the context of CCU, an outlook is given on recent developments in LCA that aim

154 ternational and domestic-health concerns-its outlook is much wider than a development or foreign-assi

155 Overall, the outlook is optimistic, but there is still some way to go

156 Finally, a possible outlook is projected for the design and syntheses of nex

157 uivalents) are also overviewed as well as an outlook is provided to highlight challenges and opportun

158 pristine as the Antarctic, the biodiversity outlook is similar to that for the rest of the planet.

159 In contrast to this early outlook, it is now clear that both reactive oxygen speci

160 We developed a water outlook model that projects water use for hydraulic frac

161 therapy is commonly used to improve the poor outlook of children with high-risk neuroblastoma, yet it

162 The outlook of EATL is poor.

163 We end with an outlook of existing challenges and near-term application

164 By altering the physical capacity and outlook of fishers, human illness shifted their effort,

165 search for better plasmonic materials and an outlook of further research directions.

166 ntion this broader context, together with an outlook of future research and applications of antiferro

167 y challenges facing perovskites, and give an outlook of future research avenues that might bring pero

168 An outlook of future scientific and technological developme

169 c enzymes in physiological regulation and an outlook of future trends apparent from current research.

170 temperature systems and evaluate the future outlook of high temperature batteries with well-controll

171 Finally, we assess the applicability and outlook of microfluidic-SANS for high-throughput and flo

172 o impact significantly on the management and outlook of patients with chronic liver disease.

173 crotizing enterocolitis may help improve the outlook of patients with this dreaded disease.

174 formation that may significantly improve the outlook of patients with this overwhelming intestinal em

175 Finally, we provide an outlook of potential areas where GO, its derivatives, an

176 nversion of rangeland into cropland; yet the outlook of rangeland biodiversity has not been considere

177 This consideration gives a general outlook of reaction routes, mechanisms, and driving forc

178 ing (CapMix) and provide perspectives on the outlook of salinity gradient power generation.

179 reflect clinicians' misconceptions about the outlook of such patients, and the importance of age in c

180 A future outlook of the advances that are likely to emerge in thi

181 logical applications, and we provide a brief outlook of the directions in which we believe SR-SIM is

182 The future outlook of the field includes refinement and development

183 n, transport), technical hurdles, and future outlook of the field is presented.

184 Current challenges and a future outlook of the field of ASCs are also discussed.

185 Furthermore, we give an outlook of the future development of MSNs-based anti-can

186 udy for the first time provides a structural outlook of the FXIIIA2B2 heterotetramer assembly, its as

187 s of beta-cell miR signaling, and provide an outlook of the opportunities and challenges ahead.

188 We conclude with an outlook of the status of the field and assess the viabil

189 le use of these examples is presented in the outlook of this review.

190 We conclude by providing an outlook of this technology platform and identifying prom

191 his MLR model also provides skilful seasonal outlooks of winter surface temperature and precipitation

192 s of patient samples likely provide a biased outlook on CLL biology.

193 Overall, this study offers a novel outlook on evoked activity through the framework of crit

194 es an expose of emerging developments and an outlook on future applications in materials and biologic

195 ver-specific immune responses and provide an outlook on future approaches.

196 We conclude with an outlook on future challenges for dynamic cell research a

197 discuss QD toxicity issues and give a short outlook on future directions of QD-based bioimaging.

198 We finally conclude by giving some outlook on future directions of this fascinating field.

199 h respect to proto-Earth and present a brief outlook on future research directions.

200 The review concludes with an outlook on how PET/CT could make a difference in drug de

201 summarize these applications and provide an outlook on how the principles of compressed sensing are

202 This review also presents the outlook on how these technologies have been successfully

203 in ischemic cardiomyopathy, and provides an outlook on how this field might evolve in the future.

204 It will also provide an outlook on how this field might evolve in the future.

205 We end with an outlook on how to further exploit the unique advantages

206 ng more confidence, happiness, and a changed outlook on life in general.

207 mographic factors, health-related QOL, mood, outlook on life, and reproductive health outcomes.

208 prostate-specific antigen (PSA) concern, and outlook on life.

209 lymph node staging are leading to changes in outlook on management of stage 1 cases and patients with

210 lasmonic nanocrystals and finally we give an outlook on nanocrystals of materials that could potentia

211 This tutorial review provides an outlook on nanomaterials that are currently being used f

212 Instead, a broad outlook on neural-circuit-damaging processes may yield i

213 We conclude the review with an outlook on outstanding questions in the field and biomed

214 esents the reader with the current state and outlook on photopharmacology.

215 Finally, we attempt an outlook on possible further developments in g-C3N4 based

216 elected recent studies, and conclude with an outlook on possible future directions for this field.

217 ng of nanomaterials and biostructures and an outlook on possible future directions in space-time, 4D

218 Additionally, we provide an outlook on possible future therapeutic uses of BAT in th

219 ta using this technique offer an encouraging outlook on robotic retroperitoneal surgery.

220 different scales, the prevailing theoretical outlook on spatial self-organization in ecology must exp

221 At the end, a summary and future outlook on the applications of water stable MOFs are sug

222 In the end, a summary and outlook on the challenges and future directions in the r

223 We conclude with an outlook on the challenges and opportunities for this eme

224 nanostructures, the review concludes with an outlook on the challenges in solar fuel generation with

225 racterizing their properties, ending with an outlook on the challenges that still lie ahead.

226 We finish with an outlook on the current challenges in the field and futur

227 We provide an up-to-date outlook on the diversity and taxonomic distribution of a

228 Moreover, we provide an outlook on the exceptional future developments of small

229 itors for cancer drug targets and provide an outlook on the exploitation of structural information in

230 We conclude by providing an outlook on the feasibility of targeting RTK networks to

231 hnology have broken even and have a positive outlook on the financial return of implementing the ReLA

232 In an outlook on the future of bioreporter technology, this re

233 A brief outlook on the future of injectable and biodegradable hy

234 of plasmonics and photovoltaics and offer an outlook on the future of solar cells based on these prin

235 We present an outlook on the future use of Earth observation technolog

236 r successes and failings, and finish with an outlook on the future.

237 detection of ovarian cancer and provides an outlook on the potential improvements in these noninvasi

238 We conclude the review with an outlook on the realization of tailored TMD-based field-e

239 state of single-cell genomics methods and an outlook on the use of single-cell techniques to decipher

240 An outlook on this developing field, including directions t

241 erstanding the importance of a comprehensive outlook on trade in health services.

242 tions that have been solved and providing an outlook on unsolved avenues.

243 eview provides an interdisciplinary critical outlook on various emerging and changing concepts in the

244 s in hematologic malignancies, and share our outlook on where this modality is likely to head in the

245 e electronic health record enables long-term outlooks on human health and disease, in conjunction wit

246 aser, review recent progress and provide our outlooks on potential applications and directions for de

247 strengthen each other through their distinct outlooks on some of the most important questions being a

248 ory (DFT) calculations to provide insightful outlooks on the charge carrier dynamics.

249 In conclusion, outlooks on the possible ways to implement microcavity-b

250 ent a summary of our progress to date and an outlook regarding future directions.

251 We conclude the review with the future outlook, remaining challenges, and emerging opportunitie

252 fying primary brain tumors for which patient outlook remains bleak.

253 ventricular end-diastolic hypertension, the outlook remains poor.

254 Finally, we conclude with an outlook section to offer some insight on the future dire

255 Our discussion- and outlook-sections will cover lentiviral targeting strateg

256 Finally, this review concludes with future outlook signifying some challenges of these nanoengineer

257 Mendel a more mathematical and probabilistic outlook than most biologists of his time.

258 Children younger than 2 years had worse outlook than older children with the same CD4%.

259 , such that many older patients had a better outlook than younger patients with adverse clinical fact

260 SP1-mediated immunity provides an optimistic outlook that a subunit MSP1 vaccine may be effective and

261 eterogeneous catalysts, and conclude with an outlook that also envisions future needs in the field.

262 A holistic outlook that encompasses the full array of selective pre

263 ped mechanistically as brain amyloidoses, an outlook that yields novel insights into potential therap

264 ld be incorporated into monthly and seasonal outlooks that are of broad importance to agriculture, in

265 The outlook, though, is influenced by age and factors relate

266 omplete remissions, allow patients with poor outlook to be treated while they are still asymptomatic.

267 An outlook to the future of research in this area is highli

268 The perspective ends up with an outlook to the future.

269 In addition we will provide an outlook toward the future of this promising subfield of

270 psy is active, the poorer is the longer term outlook; (vi) that delaying treatment, even for many yea

271 ith advanced kidney cancer, where before the outlook was often bleak.

272 As an outlook we further demonstrate the polarization based as

273 amilies should be informed about the overall outlook when they make decisions about life support and

274 uting is more energy efficient for Excel and Outlook which consumed less energy and emitted less GHG